Anti-ACPP Antibody

Recombinant research tools against human ACPP enable investigators to profile prostatic acid phosphatase, a lysosomal enzyme that has been tracked in prostate cancer biomarker workflows for decades. The polyclonal reagent, raised in rabbit, recognizes both human and rodent orthologues, supporting Western blot detection of the ~50 kDa glycoprotein in cell lysates and immunohistochemistry on fixed tissue sections.

Antibodies.com supplies the antibody at 1 mg/ml in PBS with 0.1% sodium azide and 50% glycerol as a stabilizer, packaged as a 100 µl aliquot intended for repeated use when stored refrigerated and protected from light. The format is compatible with standard chromogenic and fluorescence IHC protocols as well as PVDF or nitrocellulose membrane workflows, allowing a single lot to serve both validation and discovery studies on prostate, neuronal, and endothelial samples where ACPP has been reported.

Beyond oncology, the reagent supports neuroscience and vascular biology projects that examine non-prostatic ACPP expression, including dorsal root ganglion neurons and certain endothelial populations. Investigators running WB and IHC in parallel benefit from the unconjugated presentation, which permits flexible pairing with HRP, biotin, or fluorophore-labelled secondary reagents of their own choosing.